Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival

Cancer Research

Volumn 64, Issue 1, 2004, Pages 128-134

  Van Ginkel, Paul R ^a   Gee, Ricardo L ^a   Shearer, Rebecca L ^a   Subramanian, Lalita ^a   Walker, Teresa M ^a   Albert, Daniel M ^a   Meisner, Lorraine F ^b   Varnum, Brian C ^c   Polans, Arthur S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; COMPLEMENTARY DNA; CYSTEINE RICH PROTEIN 61; GROWTH ARREST SPECIFIC PROTEIN 6; LIGAND; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE AXL; TRYPAN BLUE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA MICROARRAY; DORMANCY; DOWN REGULATION; ENUCLEATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA CELL; METASTASIS; MITOGENESIS; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RIBONUCLEASE PROTECTION ASSAY; STIMULATION; TUMOR GROWTH; UPREGULATION; UVEA MELANOMA; WESTERN BLOTTING;

BASE SEQUENCE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOCYTES; MELANOMA; ONCOGENE PROTEINS; POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 1642535589     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0245     Document Type: Article

References (56)

1. Albert, D. M., Niffenegger, A. S., and Willson, J. K. V. Treatment of metastatic uveal melanoma: review and recommendations. Surv. Ophthalmol., 36: 429-438, 1992.
2. Kath, R., Hayungs, J., Bornfeld, N., Sauerwein, W., Hoffken, K., and Seeber, S. Prognosis and treatment of disseminated uveal melanoma. Cancer (Phila.), 72: 2219-2223, 1993.
3. Pach, J. M., and Robertson, D. M. Metastasis from untreated uveal melanomas. Arch. Ophthalmol., 104: 1624-1625, 1986.
4. Wagoner, M. D., and Albert, D. M. The incidence of metastases from untreated ciliary body and choroidal melanoma. Arch. Ophthalmol., 100: 939-940, 1982.
5. Wang, M. X., Shields, J. A., and Donoso, L. A. Subclinical metastasis of uveal melanoma. Int. Ophthalmol. Clin., 33: 119-127, 1993.
6. Shields, J. A., Augsburger, J. J., Donoso, L. A., Bernardino, V. B., Jr., and Porienar, M. Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am. J. Ophthalmol., 100: 666-668, 1985.
7. Coupland, S. E., Sidiki, S., Clark, B., Kyle, P., and Lee, W. R. Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation. Arch. Ophthalmol., 114: 751-756, 1996.
8. Lorrigan, J. G., Wallace, S., and Mavligit, G. M. The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. Am. J. Radiol., 157: 279-281, 1991.
9. Yefenof, E. Cancer dormancy: from observation to investigation and onto clinical intervention. Semin. Cancer Biol., 11: 269-270, 2001.
10. O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitsch, B., Prokop, C., Espinosa, R., III, Le Beau, M. M., Earp, H. S., and Liu, E. T. axl, a transforming gene isolated from primary myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol., 11: 5016-5031, 1991.
11. Janssen, J. W. G., Schulz, A. S., Steenvoorden, A. C. M., Schmidberger, M., Strehl, S., Ambros, P. F., and Bartram, C. R. A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene, 6: 2113-2120, 1991.
12. Craven, R. J., Xu, L., Weiner, T. M., Fridell, Y-W., Dent, G. A., Srivastava, S., Varnum, B., Liu, E. T., and Cance, W. G. Receptor tyrosine kinases expressed in metastatic colon cancer. Int. J. Cancer, 60: 791-797, 1995.
13. Weiner, T. M., Liu, E. T., Craven, R. J., and Cance, W. G. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosinc kinases in human soft tissue tumors. Ann. Surg. Oncol., 1: 18-27, 1994.
14. Burchert, A., Attar, E. C., McCloskey, P., Fridell, Y-C., and Liu, E. T. Determinants for transformation induced by the Axl receptor tyrosine kinase. Oncogene, 16: 3177-3187, 1998.
15. Jacob, A. N. K., Kalapurakal, J., Davidson, W. R., Kandpal, G., Dunson, N., Prashar, Y., and Kandpal, R. P. A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145. Cancer Detect. Prev., 23: 325-332, 1999.
16. Wu. C. W., Li, A. F., Chi, C. W., Lai, C. H., Huang, C. L., Lo, S. S., Lui, W. Y., and Lin, W. C. Clinical significance of AXL kinase family in gastric cancer. Anticancer Res., 22: 1071-1078, 2002.
17. Sun, W. S., Fujimoto, J., and Tamaya, T. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinase Axl and SKY in human uterine endometrial cancers. Ann. Oncol., 14: 898-906, 2003.
18. Mark, M. R., Chen, J., Hammonds, R. G., Sadick, M., and Godowsk, P. J. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J. Biol. Chem., 271: 9785-9789, 1996.
19. Nagata, K., Ohashi, K., Nakano, T., Arita, H., Zong, C., Hanafusa, H., and Mizuno K. Identification of the product of the growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J. Biol. Chem., 271: 30022-30027, 1996.
20. Braunger, J., Schleithoff, L., Schulz, A. S., Kessler, H., Lammers, R., Ullrich, A., Bartram, C. R., and Janssen. J. W. G. Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site. Oncogene. 14: 2619-2631, 1997.
21. Manfioletti, G., Brancolini, C., Avanzi, G., and Schneider, C. The protein encoded by a growth arrest-specific gene (gas6) is a member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol., 13: 4976-4985, 1993.
22. Loeser, R. F., Varnum, B., Carlson, C. S., Goldring, M. B., Liu, E. T., Sadiev, S. K., Kute, T. E., and Wallin, R. Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor Axl. Arthritis Rheum., 40: 1455-1465, 1997.
23. Yanagita, M., Ishii, K., Ozaki, H., Arai, H., Nakano, T., Ohashi, K., Mizuno, K., Kita, T., and Doi, T. Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J. Am. Soc. Nephrol., 10: 2503-2509, 1999.
24. Healy, A. M., Schwartz, J. J., Zhu, X. H., Herrick, B. E., Varnum, B., and Farber, H. W. Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 280: LI273-LI281, 2001.
25. Lee, W. P., Wen, Y., Varnum, B., and Hung, M. C. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis. Oncogene, 21: 329-336, 2002.
26. Shankar, S. L., O'Guin, K., Cammer, M., McMorris, F. A., Stitt, T. N., Basch, R. S., Varnum, B., and Shafit-Zagardo, B. The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. J. Neurosci., 23: 4208-4218, 2003.
27. Li, R., Chen, J., Hammonds, G., Phillips, H., Armanini, M., Wood, P., et al. Identification of Gas6 as a growth factor for human Schwann cells. J. Neurosci., 16: 2012-2019, 1996.
28. Goruppi, S., Ruaro, E., and Schneider, C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene, 12: 471-480, 1996.
29. Goruppi, S., Ruaro, E., Varnum, B., and Schneider, C. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic activities in NIH 3T3 fibroblasts. Mol. Cell. Biol., 17: 4442-4453, 1997.
30. Goruppi, S., Ruaro, E., Varnum, B., and Schneider, C. Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene, 18: 4224-4236, 1999.
31. Walker, T. M., van Ginkel, P. R., Gee, R. L., Ahmadi, H., Subramanian, L., Ksander, B. R., Meisner, L. F., Albert, D. M., and Polans, A. S. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch. Ophthalmol., 120: 1719-1725, 2002.
32. Hu, D-N., McCormick, S. A., Ritch, R., and Pelton-Henrion, K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest. Ophthalmol. Vis. Sci., 34: 2210-2219, 1993.
33. van Ginkel, P. R., and Hauswirth, W. W. Parallel regulation of fetal gene expression in different photoreceptor cell types. J. Biol. Chem., 269: 4986-4992, 1994.
34. Schlamp, C. L., and Nickells, R. W. Light and dark cause a shift in spatial expression of a neuropeptide processing enzyme in rat retina. J. Neurosci., 16: 2164-2171, 1996.
35. Stanta, G., and Schneider, C. RNA extracted from paraffin-embedded human tissues is amenable to analysis by RCR amplification. Biotechniques, 11: 304-308, 1991.
36. PE Applied Biosystems: ABI Prism 7700 Sequence Detection System: relative quantitation of gene expression. User bulletin #2: Rev B, Foster City, CA, Applied Biosystems, pp. 1-36, 2001.
37. Crosier, K. E., and Crosier, P. S. New insights into the control of cell growth: the role of the Axl family. Pathology, 29: 131-135, 1997.
38. O'Bryan, J. P., Fridell, Y-W., Koski, R., Varnum, B., and Liu, E. T. The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. J. Biol. Chem., 270: 551-557, 1995.
39. Holmgren, L. M., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153. 1995.
40. Varghese, H. J., Davidson, M. T., MacDonald, I. C., Wilson, S. M., Nadkarni, K. V., Groom, A. C., and Chambers, A. F. Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Res., 62: 887-891, 2002.
41. 1 and cell surface heparan sulfate proteoglycans. J. Biol. Chem., 275: 24953-24961, 2000.
42. Chen, C. C., Mo, F. E., and Lau, L. F. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J. Biol. Chem., 276: 47329-47337, 2001.
43. 3. J. Biol. Chem., 274: 24321-24327, 1999.
44. Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., and Lau, L. F. Cyr61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA, 95: 6355-6360, 1998.
45. Tong, X., Xie, D., O'Kelly, J., Miller, C. W., Muller-Tidow, C., and Koeffler, H. P. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J. Biol. Chem., 276: 47709-47714, 2001.
46. Tsai, M. S., Bogart, D. F., Li, P., Mehmi, I., and Lupu, R. Expression and regulation of Cyr61 in human breast cancer cell lines. Oncogene, 21: 964-973, 2002.
47. Pilarsky, C. P., Schmidt, U., Eissrich, C., Stade, J., Froschermaier, S. E., Haase, M., Faller, G., Kirchner, T. W., and Wirth, M. P. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer. Prostate, 36: 85-91, 1998.
48. Leu, S. J., Lam, S. C., and Lau, L. F. Pro-angiogenic activities of CYR61 (CCNI) mediated through integrins αvβ3 and α6β1 in human umbilical vein endothelial cells. J. Biol. Chem., 277: 46248-46255, 2002.
49. Ma, D., and Niederkom, J. Y. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest. Ophthalmol. Vis. Sci., 39: 1067-1075, 1998.
50. All-Ericsson, C., Gimita, L., Seregard, S., Bartolazzi, A., Jager, M. J., and Larsson, O. Insulin-like growth factor-I receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest. Ophthalmol. Vis. Sci., 43: 1-8, 2002.
51. Hendrix, M. J. C., Seftor, E. A., Seftor, R. E. B., Kirschmann, D. A., Gardner, L. M., Boldt, H. C., Meyer, M., Pe'er, J., and Folberg, R. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor scatter factor (HGF/SF). Am. J. Pathol., 152: 855-863, 1998.
52. Radinsky, R. Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur. J. Cancer, 31: 1091-1095, 1995.
53. Khazaie, K., Schirrmacher, V., and Lichtner, R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 1993: 255-274, 1993.
54. Lamszus, K., Jin, L., Fuchs, A., Shi, E., Chowdhury, S., Yao, Y., Polverini, P. J., Laterra, J., Goldberg, I. D., and Rosen, E. M. Scatter factor stimulates tumor growth and angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab. Invest., 76: 339-353, 1997.
55. Hu, Z. W., and Garen, A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc. Natl. Acad. Sci. USA, 98: 12180-12185, 2001.
56. Blume-Jensen, P., and Hunter, T. Oncogenic kinase signalling. Nature (Lond.), 411: 355-365, 2001.